Word

GC MOGAM

Status

Dead

Status Code

606

Status Date

Monday, May 30, 2022

Serial Number

88075940

Mark Type

3000

Filing Date

Monday, August 13, 2018

Published for Opposition

Tuesday, February 26, 2019

Abandoned Date

Monday, May 30, 2022

Trademark Owner History

Green Cross Holdings Corporation - Owner At Publication

Classifications

5 Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, hepatitis, HIV, Hunter syndrome, hemophilia, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, clostridium tetani, influenza, chronic pain and kidney diseases; pharmaceutical preparations for use in ocular or intraocular surgery, chemotherapy, dermatology and urology; blood plasma derivatives for medical purposes; vaccines; enzyme preparations for medical purposes; protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing and treatment of hepatitis B and influenza

35 Wholesale distributorships and retail store services featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses

42 Research and development, laboratory and scientific research in the field of pharmaceuticals, vaccines, blood plasma preparations, recombinant proteins and antibodies

The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross is the wording "GC MOGAM" with "GC" in dark blue, and "MOGAM" in green.
The color(s) green, yellow, orange, red, and dark blue is/are claimed as a feature of the mark.

Trademark Events

May 31, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

May 30, 2022

Abandonment - No Use Statement Filed

Oct 23, 2021

Notice Of Approval Of Extension Request E-Mailed

Oct 22, 2021

Sou Extension 5 Granted

Oct 14, 2021

Sou Extension 5 Filed

Oct 22, 2021

Case Assigned To Intent To Use Paralegal

Oct 14, 2021

Sou Teas Extension Received

Apr 21, 2021

Notice Of Approval Of Extension Request E-Mailed

Apr 19, 2021

Sou Extension 4 Granted

Apr 19, 2021

Sou Extension 4 Filed

Apr 19, 2021

Sou Teas Extension Received

Sep 4, 2020

Notice Of Approval Of Extension Request E-Mailed

Sep 2, 2020

Sou Extension 3 Granted

Sep 2, 2020

Sou Extension 3 Filed

Sep 2, 2020

Sou Teas Extension Received

Mar 5, 2020

Notice Of Approval Of Extension Request E-Mailed

Mar 3, 2020

Sou Extension 2 Granted

Mar 3, 2020

Sou Extension 2 Filed

Mar 3, 2020

Sou Teas Extension Received

Oct 10, 2019

Notice Of Approval Of Extension Request E-Mailed

Oct 8, 2019

Sou Extension 1 Granted

Oct 8, 2019

Sou Extension 1 Filed

Oct 8, 2019

Sou Teas Extension Received

Apr 23, 2019

Noa E-Mailed - Sou Required From Applicant

Feb 26, 2019

Official Gazette Publication Confirmation E-Mailed

Feb 26, 2019

Published For Opposition

Feb 6, 2019

Notification Of Notice Of Publication E-Mailed

Jan 18, 2019

Approved For Pub - Principal Register

Jan 18, 2019

Teas/Email Correspondence Entered

Jan 18, 2019

Correspondence Received In Law Office

Jan 18, 2019

Assigned To Lie

Jan 15, 2019

Teas Response To Office Action Received

Oct 10, 2018

Notification Of Non-Final Action E-Mailed

Oct 10, 2018

Non-Final Action E-Mailed

Oct 10, 2018

Non-Final Action Written

Oct 9, 2018

Assigned To Examiner

Aug 22, 2018

Notice Of Design Search Code E-Mailed

Aug 21, 2018

New Application Office Supplied Data Entered

Aug 16, 2018

New Application Entered